Also trades as: CYP.AX (ASX) · $vol 0M
CYYNF Earnings
Cynata Therapeutics Limited
1W: -83.7%
1M: -83.7%
3M: -84.4%
YTD: -99.1%
1Y: -98.8%
3Y: -98.2%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Last Earnings
2026-08-31
EPS
A$-0.02 (US$-0.01)
▼ Miss +0.0%
Revenue
—
Estimate vs Actual
Earnings Surprise History
1/14
EPS Beats
0/14
Revenue Beats
7%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | annual | 2027-06-30 | A$-0.03 | A$-0.03 | — | A$31,658,328 | A$31,479,744 |
| 2026-10-02 | annual | 2028-06-30 | A$-0.09 | A$-0.09 | — | A$2,218,099 | A$2,205,587 |
| 2026-10-01 | annual | 2027-06-30 | A$-0.03 | A$-0.03 | — | A$31,805,184 | A$31,658,328 |
| 2026-10-01 | annual | 2028-06-30 | A$-0.09 | A$-0.09 | — | A$2,228,388 | A$2,218,099 |
| 2026-09-30 | annual | 2027-06-30 | A$-0.03 | A$-0.03 | — | A$31,832,379 | A$31,805,184 |
| 2026-09-30 | annual | 2028-06-30 | A$-0.09 | A$-0.09 | — | A$2,230,294 | A$2,228,388 |
| 2026-09-29 | annual | 2027-06-30 | A$-0.03 | A$-0.03 | — | A$31,776,175 | A$31,832,379 |
| 2026-09-29 | annual | 2028-06-30 | A$-0.09 | A$-0.09 | — | A$2,226,356 | A$2,230,294 |
| 2026-09-28 | annual | 2027-06-30 | A$-0.03 | A$-0.03 | — | A$31,889,036 | A$31,776,175 |
| 2026-09-28 | annual | 2028-06-30 | A$-0.09 | A$-0.09 | — | A$2,234,263 | A$2,226,356 |
| 2026-09-25 | annual | 2027-06-30 | A$-0.03 | A$-0.03 | — | A$32,257,989 | A$31,889,036 |
| 2026-09-25 | annual | 2028-06-30 | A$-0.09 | A$-0.09 | — | A$2,260,113 | A$2,234,263 |
| 2026-09-24 | annual | 2027-06-30 | A$-0.03 | A$-0.03 | — | A$32,271,134 | A$32,257,989 |
| 2026-09-24 | annual | 2028-06-30 | A$-0.09 | A$-0.09 | — | A$2,261,034 | A$2,260,113 |
| 2026-09-23 | annual | 2027-06-30 | A$-0.03 | A$-0.03 | — | A$32,258,443 | A$32,271,134 |
Earnings Call Transcripts
No transcripts available.